[Neonatal complications and birth defects in infants conceived by in vitro fertilization]

Xiao-Yan Xu1, Jing-Hui Yang, Xin-Mei Ma

  • 1Department of Pediatrics, First People's Hospital of Yunnan Province, Kunming 650032, China. erklili@sina.com.

Insights

In vitro fertilization (IVF) does not increase birth defect risks but leads to higher rates of twin pregnancy and low birth weight in infants. Avoiding prematurity and complications can reduce low birth weight incidence.

Area of Science:

  • Reproductive Medicine
  • Neonatal Health
  • Public Health

Context:

  • In vitro fertilization (IVF) is a widely used assisted reproductive technology.
  • Assessing the long-term health outcomes and survival quality of infants conceived via IVF is crucial.
  • Understanding factors contributing to neonatal complications in IVF-conceived infants is essential for improving care.

Purpose:

  • To investigate the survival quality of infants conceived by in vitro fertilization (IVF).
  • To identify factors contributing to birth defects and neonatal complications in IVF infants.
  • To compare outcomes between IVF and naturally conceived infants.

Summary:

  • The study compared 150 IVF infants with 200 naturally conceived infants.
  • IVF infants showed higher rates of twin pregnancy and low birth weight, with no significant difference in birth defects.
  • Maternal age, cesarean section, and pregnancy complications were higher in the IVF group.

Impact:

  • IVF is associated with increased risks of twin pregnancy and low birth weight, necessitating targeted neonatal care.
  • Identifying risk factors like prematurity and twin pregnancy can guide interventions to improve IVF infant outcomes.
  • This research informs clinical practice and parental counseling regarding IVF conception and neonatal health.
Abstract

Related Concept Videos

In Vitro Fertilization01:24

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
1.4K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
47.6K
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
150